Live Updates: COVID-19 Cases
  • World 18,463,904
    World
    Confirmed: 18,463,904
    Active: 6,074,703
    Recovered: 11,691,464
    Death: 697,737
  • USA 4,862,285
    USA
    Confirmed: 4,862,285
    Active: 2,255,829
    Recovered: 2,447,525
    Death: 158,931
  • Brazil 2,751,665
    Brazil
    Confirmed: 2,751,665
    Active: 744,644
    Recovered: 1,912,319
    Death: 94,702
  • India 1,858,689
    India
    Confirmed: 1,858,689
    Active: 588,005
    Recovered: 1,231,682
    Death: 39,002
  • Russia 861,423
    Russia
    Confirmed: 861,423
    Active: 185,601
    Recovered: 661,471
    Death: 14,351
  • South Africa 516,862
    South Africa
    Confirmed: 516,862
    Active: 150,286
    Recovered: 358,037
    Death: 8,539
  • Mexico 443,813
    Mexico
    Confirmed: 443,813
    Active: 100,124
    Recovered: 295,677
    Death: 48,012
  • Peru 433,100
    Peru
    Confirmed: 433,100
    Active: 115,198
    Recovered: 298,091
    Death: 19,811
  • Chile 361,493
    Chile
    Confirmed: 361,493
    Active: 17,810
    Recovered: 333,976
    Death: 9,707
  • Spain 344,134
    Spain
    Confirmed: 344,134
    Active: 315,662
    Recovered: ?
    Death: 28,472
  • Iran 312,035
    Iran
    Confirmed: 312,035
    Active: 24,402
    Recovered: 270,228
    Death: 17,405
  • UK 305,623
    UK
    Confirmed: 305,623
    Active: 259,413
    Recovered: ?
    Death: 46,210
  • Pakistan 280,461
    Pakistan
    Confirmed: 280,461
    Active: 25,065
    Recovered: 249,397
    Death: 5,999
  • Saudi Arabia 280,093
    Saudi Arabia
    Confirmed: 280,093
    Active: 35,089
    Recovered: 242,055
    Death: 2,949
  • Italy 248,229
    Italy
    Confirmed: 248,229
    Active: 12,474
    Recovered: 200,589
    Death: 35,166
  • Bangladesh 242,102
    Bangladesh
    Confirmed: 242,102
    Active: 101,013
    Recovered: 137,905
    Death: 3,184
  • Turkey 233,851
    Turkey
    Confirmed: 233,851
    Active: 10,607
    Recovered: 217,497
    Death: 5,747
  • Germany 212,320
    Germany
    Confirmed: 212,320
    Active: 8,388
    Recovered: 194,700
    Death: 9,232
  • France 191,295
    France
    Confirmed: 191,295
    Active: 79,501
    Recovered: 81,500
    Death: 30,294
  • Canada 117,031
    Canada
    Confirmed: 117,031
    Active: 6,487
    Recovered: 101,597
    Death: 8,947
  • China 84,464
    China
    Confirmed: 84,464
    Active: 800
    Recovered: 79,030
    Death: 4,634
  • Netherlands 55,470
    Netherlands
    Confirmed: 55,470
    Active: 49,321
    Recovered: ?
    Death: 6,149
  • Australia 18,730
    Australia
    Confirmed: 18,730
    Active: 7,876
    Recovered: 10,622
    Death: 232
  • S. Korea 14,423
    S. Korea
    Confirmed: 14,423
    Active: 770
    Recovered: 13,352
    Death: 301
  • New Zealand 1,567
    New Zealand
    Confirmed: 1,567
    Active: 22
    Recovered: 1,523
    Death: 22

Hydroxychloroquine-azithromycin combo may be potentially lethal

Author at TechGenyz Health
Hydroxychloroquine
Hydroxychloroquine | Representation image/Freepik

Hydroxychloroquine and azithromycin, which have been proposed for treatment of COVID-19 patients, are a potentially lethal combination and may have a serious impact on the cardiovascular system, according to a study.

The researchers, including those from Vanderbilt University and Stanford University in the US, carried out an observational, retrospective meta-analysis of a WHO database encompassing over 21 million adverse event case reports.

The reports span across all medication classes from over 130 countries between November 14, 1967, and March 1, 2020 — mainly before the COVID-19 pandemic.

The study, published in the journal Circulation, compared cardiovascular adverse-drug-reactions (CV-ADRs) in patients who received hydroxychloroquine, azithromycin, or the combination of both medications with all other cardiovascular medications in the database.

Hydroxychloroquine and azithromycin, alone or in combination, have been proposed for treatment of COVID-19 patients, the researchers said.

They explained that reports of potentially lethal acute cardiac proarrhythmogenic effects — promoting irregular heart rhythms — have been described mainly with azithromycin but also with hydroxychloroquine.

Their combination yielded an even stronger signal, the scientists said.

Hydroxychloroquine was also associated with potentially lethal heart failure when exposure was prolonged over several months, according to the researchers.

From the more than 21 million case reports of adverse drug reactions, the researchers extracted case reports for hydroxychloroquine and azithromycin, alone or in combination.

They found that 76,822 adverse event reports were associated with hydroxychloroquine alone, and in 28.4 percent of those cases (21,808), the drug was suspected to be associated with the adverse event.

The study found that 89,692 adverse event reports were associated with azithromycin alone, and in 60.8 per cent of those cases (54,533), the medication was suspected to be associated with the adverse events.

The researchers said 607 adverse event reports were associated with the combination of both medications.

Hydroxychloroquine was significantly associated with the development of conduction disorders, and heart failure, they said.

On Monday, the World Health Organization also suspended testing hydroxychloroquine in COVID-19 patients due to safety concerns, WHO Director-General Tedros Adhanom Ghebreyesus said.

Career

Subscribe